Trial intelligence / Profile preview

Citramag and Senna vs Metoclopramide for Capsule Endoscopy

NCT00275184Phase 3Unknown

Sponsor
London North West University Healthcare NHS Trust
Start
Jan 2006
Modality
Implantable Devices, Transdermal Patches, Inhalation Devices
Countries
1
01

Overview

Phase 3, randomised trial in Small bowel disorders, Gastrointestinal Bleeding (GIB) and refractory anemia (RA) comparing Citramag + Senna with Metoclopramide (2 arms). Primary endpoints: Quality of capsule endoscopic images, Stomach and small bowel transit times and 1 more. Status: unknown.

02

Drugs

RMJH-111bsennosidesmetoclopramide
03

Conditions

Small bowel disordersGastrointestinal Bleeding (GIB)refractory anemia (RA)

Beyond the preview

Go deeper on NCT00275184.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00275184.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call